HMGCR and ovarian carcinoma: To determine if dysfunction of TP53 might contribute to altered HMGCR expression in ovarian cancer cells, we ectopically expressed wild-type and R248W, R175H, and R273H gain-of-function p53 variants in SkOv-3 ovarian cancer cells which lack endogenous p53 protein31.